These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9472204)

  • 1. A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study.
    Yerly S; Perneger TV; Hirschel B; Dubuis O; Matter L; Malinverni R; Furrer H; Perrin L
    Arch Intern Med; 1998 Feb; 158(3):247-52. PubMed ID: 9472204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.
    Anastos K; Barrón Y; Cohen MH; Greenblatt RM; Minkoff H; Levine A; Young M; Gange SJ
    Ann Intern Med; 2004 Feb; 140(4):256-64. PubMed ID: 14970148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 RNA levels and the development of clinical disease. North American Lamivudine HIV Working Group.
    Phillips AN; Eron JJ; Bartlett JA; Rubin M; Johnson J; Price S; Self P; Hill AM
    AIDS; 1996 Jul; 10(8):859-65. PubMed ID: 8828743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.
    Mellors JW; Muñoz A; Giorgi JV; Margolick JB; Tassoni CJ; Gupta P; Kingsley LA; Todd JA; Saah AJ; Detels R; Phair JP; Rinaldo CR
    Ann Intern Med; 1997 Jun; 126(12):946-54. PubMed ID: 9182471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
    Kim S; Hughes MD; Hammer SM; Jackson JB; DeGruttola V; Katzenstein DA
    AIDS Res Hum Retroviruses; 2000 May; 16(7):645-53. PubMed ID: 10791875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.
    Merigan TC; Hirsch RL; Fisher AC; Meyerson LA; Goldstein G; Winters MA
    AIDS; 1996 Feb; 10(2):159-65. PubMed ID: 8838703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study.
    Anastos K; Kalish LA; Hessol N; Weiser B; Melnick S; Burns D; Delapenha R; DeHovitz J; Cohen M; Meyer W; Bremer J; Kovacs A
    AIDS; 1999 Sep; 13(13):1717-26. PubMed ID: 10509574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l.
    Coakley EP; Samore MH; Gillis JM; Hughes MD; Hammer SM
    AIDS; 2000 Jun; 14(9):1147-53. PubMed ID: 10894278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
    JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
    Arduino JM; Fischl MA; Stanley K; Collier AC; Spiegelman D
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1099-105. PubMed ID: 11522179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels.
    Ullum H; Lepri AC; Katzenstein TL; Phillips AN; Skinhøj P; Gerstoft J; Pedersen BK
    Scand J Infect Dis; 2000; 32(4):371-6. PubMed ID: 10959644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ cell counts and HIV-RNA levels do not predict outcomes of community-acquired pneumonia in hospitalized HIV-infected patients.
    Bordon J; Kapoor R; Martinez C; Portela D; Duvvuri P; Klochko A; Ayesu K; Peyrani P; Cillóniz C; Wiemken T; Parra A; Torres A; Rello J; Ramirez J
    Int J Infect Dis; 2011 Dec; 15(12):e822-7. PubMed ID: 21885316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
    Zangerle R; Steinhuber S; Sarcletti M; Dierich MP; Wachter H; Fuchs D; Möst J
    Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients.
    Valentine ME; Jackson CR; Vavro C; Wilfert CM; McClernon D; St Clair M; Katz SL; McKinney RE
    Pediatr Infect Dis J; 1998 Jan; 17(1):18-23. PubMed ID: 9469389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming laboratory test results to improve clinical outcome predictions in HIV patients. Swiss HIV Cohort Study.
    Perneger TV; Yerly S; Perrin L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(5):442-9. PubMed ID: 9562047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
    Hughes MD; Johnson VA; Hirsch MS; Bremer JW; Elbeik T; Erice A; Kuritzkes DR; Scott WA; Spector SA; Basgoz N; Fischl MA; D'Aquila RT
    Ann Intern Med; 1997 Jun; 126(12):929-38. PubMed ID: 9182469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users.
    Carbone J; Gil J; Benito JM; Navarro J; Muñóz-Fernández A; Bartolomé J; Zabay JM; López F; Fernández-Cruz E
    AIDS; 2000 Dec; 14(18):2823-9. PubMed ID: 11153663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of plasma HIV RNA among highly active antiretroviral therapy users.
    Tarwater PM; Gallant JE; Mellors JW; Gore ME; Phair JP; Detels R; Margolick JB; Muñoz A
    AIDS; 2004 Dec; 18(18):2419-23. PubMed ID: 15622318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection.
    Cozzi Lepri A; Katzenstein TL; Ullum H; Phillips AN; Skinhøj P; Gerstoft J; Pedersen BK
    AIDS; 1998 Sep; 12(13):1639-43. PubMed ID: 9764783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
    N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.